Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial

The Lancet Neurology · Published 2026-06-17 · DOI 10.1016/s1474-4422(26)00158-4

Free full text

Authors (17)

Kyriakos Martakis, Tatiana Bremova-Ertl, Clare Bolton, Tomas Foltan, Maria del Mar Garcia Romero, Matthias Gautschi, Vladimir Han, Andreas Hahn, Miriam Kolnikova, Ouliana Panagioti, Susan Perlman, Manish Prasad, Jeremey Schmahmann, Matej Skorvanek, Nivedita Thakur, Moritz Thiel, Franziska Hoche

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Martakis, K., Bremova-Ertl, T., Bolton, C., et al. (2026). Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(26)00158-4

Related articles